Stock listing
SET:IVF.R Inspire IVF Public Company Limited (อินสไปร์ ไอวีเอฟ) หุ้น
Thai listing (SET) of Inspire IVF Public Company Limited · home listing SET:IVF
Follow Inspire IVF Public Company Limited into a list and get an email when it puts out news.
Home listing price · SET:IVF
0.54 THB -0.01 (-1.8%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SET:IVF
- Day range
- 0.52 – 0.55 THBNov 20, 2026
- Volume
- 672,148 sharesNov 20, 2026
- Market cap
- 237.6M THBAt the close on Nov 20, 2026 · price × 440.0M shares outstanding
- Traded on an average day
- 635,941 THBMedian day 167,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SET:IVF · THB, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.54 | -0.01 | -1.8% | 0.55 | 0.55 | 0.52 | 672,148 | |
| 0.55 | 0.00 | 0.0% | 0.55 | 0.55 | 0.54 | 29,500 | |
| 0.55 | 0.00 | 0.0% | 0.55 | 0.56 | 0.54 | 73,401 | |
| 0.55 | 0.00 | 0.0% | 0.56 | 0.56 | 0.53 | 216,703 | |
| 0.55 | -0.01 | -1.8% | 0.56 | 0.57 | 0.53 | 156,599 | |
| 0.56 | -0.02 | -3.4% | 0.56 | 0.58 | 0.56 | 113,200 | |
| 0.58 | +0.01 | +1.8% | 0.56 | 0.58 | 0.56 | 23,500 | |
| 0.57 | 0.00 | 0.0% | 0.56 | 0.57 | 0.56 | 47,300 | |
| 0.57 | 0.00 | 0.0% | 0.56 | 0.58 | 0.56 | 159,810 | |
| 0.57 | +0.01 | +1.8% | 0.56 | 0.58 | 0.55 | 167,400 | |
| 0.56 | -0.01 | -1.8% | 0.56 | 0.56 | 0.55 | 124,002 | |
| 0.57 | +0.01 | +1.8% | 0.56 | 0.58 | 0.55 | 101,600 | |
| 0.56 | -0.01 | -1.8% | 0.56 | 0.59 | 0.54 | 532,283 | |
| 0.57 | -0.13 | -18.6% | 0.60 | 0.61 | 0.56 | 1,011,300 | |
| 0.70 | -0.01 | -1.4% | 0.71 | 0.71 | 0.70 | 25,900 | |
| 0.71 | -0.01 | -1.4% | 0.70 | 0.72 | 0.70 | 484,700 | |
| 0.72 | +0.01 | +1.4% | 0.72 | 0.72 | 0.71 | 1,900 | |
| 0.71 | -0.02 | -2.7% | 0.72 | 0.72 | 0.71 | 1,252,700 | |
| 0.73 | +0.02 | +2.8% | 0.72 | 0.73 | 0.72 | 21,700 | |
| 0.71 | 0.00 | 0.0% | 0.73 | 0.73 | 0.71 | 45,000 | |
| 0.71 | 0.00 | 0.0% | 0.73 | 0.73 | 0.71 | 137,300 | |
| 0.71 | -0.01 | -1.4% | 0.73 | 0.74 | 0.70 | 2,048,000 | |
| 0.72 | 0.00 | 0.0% | 0.72 | 0.73 | 0.72 | 122,700 | |
| 0.72 | -0.03 | -4.0% | 0.75 | 0.76 | 0.72 | 1,905,300 | |
| 0.75 | 0.00 | 0.0% | 0.77 | 0.79 | 0.75 | 5,911,100 | |
| 0.75 | 0.00 | 0.0% | 0.74 | 0.79 | 0.73 | 2,048,800 | |
| 0.75 | +0.01 | +1.4% | 0.74 | 0.75 | 0.74 | 165,700 | |
| 0.74 | 0.00 | 0.0% | 0.74 | 0.75 | 0.74 | 202,900 | |
| 0.74 | -0.02 | -2.6% | 0.75 | 0.75 | 0.72 | 1,314,400 | |
| 0.76 | 0.00 | 0.0% | 0.75 | 0.76 | 0.75 | 14,400 | |
| 0.76 | +0.01 | +1.3% | 0.75 | 0.76 | 0.74 | 212,103 | |
| 0.75 | 0.00 | 0.0% | 0.75 | 0.79 | 0.75 | 2,768,503 | |
| 0.75 | +0.02 | +2.7% | 0.74 | 0.75 | 0.74 | 265,600 | |
| 0.73 | -0.02 | -2.7% | 0.75 | 0.75 | 0.73 | 186,000 | |
| 0.75 | +0.03 | +4.2% | 0.73 | 0.75 | 0.73 | 330,400 | |
| 0.72 | -0.02 | -2.7% | 0.76 | 0.76 | 0.72 | 241,800 | |
| 0.74 | 0.00 | 0.0% | 0.74 | 0.76 | 0.74 | 97,510 | |
| 0.74 | -0.01 | -1.3% | 0.75 | 0.75 | 0.74 | 162,900 | |
| 0.75 | -0.01 | -1.3% | 0.75 | 0.76 | 0.75 | 89,800 | |
| 0.76 | 0.00 | 0.0% | 0.76 | 0.77 | 0.75 | 192,500 | |
| 0.76 | +0.01 | +1.3% | 0.76 | 0.76 | 0.75 | 210,000 | |
| 0.75 | -0.02 | -2.6% | 0.76 | 0.77 | 0.75 | 218,600 | |
| 0.77 | +0.02 | +2.7% | 0.75 | 0.78 | 0.75 | 1,504,559 | |
| 0.75 | +0.01 | +1.4% | 0.74 | 0.76 | 0.74 | 716,900 | |
| 0.74 | -0.05 | -6.3% | 0.79 | 0.79 | 0.73 | 3,791,300 | |
| 0.79 | +0.02 | +2.6% | 0.79 | 0.85 | 0.77 | 14,398,802 | |
| 0.77 | +0.01 | +1.3% | 0.77 | 0.77 | 0.76 | 162,500 | |
| 0.76 | -0.01 | -1.3% | 0.78 | 0.78 | 0.76 | 155,709 | |
| 0.77 | -0.01 | -1.3% | 0.78 | 0.78 | 0.77 | 22,000 | |
| 0.78 | +0.02 | +2.6% | 0.77 | 0.79 | 0.76 | 226,100 | |
| 0.76 | -0.01 | -1.3% | 0.76 | 0.78 | 0.76 | 102,100 | |
| 0.77 | +0.01 | +1.3% | 0.77 | 0.77 | 0.77 | 68,600 | |
| 0.76 | 0.00 | 0.0% | 0.77 | 0.78 | 0.76 | 103,700 |
- Ticker
- SET:IVF.R
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- SET
- Currency
- THB
Inspire IVF Public Company Limited on 6ix
- Sector
- Health care
- Industry
- Health care services
Where Inspire IVF Public Company Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SET:IVF อินสไปร์ ไอวีเอฟ · Home listing | SET | Thailand | THB |
| SET:IVF.R อินสไปร์ ไอวีเอฟ · This page | SET | Thailand | THB |
| SET:IVF.F อินสไปร์ ไอวีเอฟ | SET | Thailand | THB |
Valuation
EV/sales −3.6× against a median of 0.7×: the lowest of 10 Health care services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- −212.9M THB
- P/E
- Loss
- EV/sales
- −3.6×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.5×
- Gross margin
- 26.2%
- Operating margin
- −57.1%
- Net margin
- −39.6%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Inspire IVF Public Company Limited · SET:IVF | US$7.00M | −US$6.27M | n/a | −3.6× | n/a | 0.5× | −39.6% | 0.0× | n/a |
| InteliCare Holdings Limited · ASX:ICR | US$8.05M | US$8.25M | n/a | 13.0× | n/a | n/a | −234.6% | n/a | n/a |
| SEI Medical Public Co., Ltd. · SET:SEI | US$7.91M | US$4.28M | 8.7× | 0.3× | 2.5× | 0.9× | 7.5% | 0.0× | n/a |
| Medicskin Holdings Ltd. · HKEX:8307 | US$7.84M | US$6.33M | 65.7× | 1.0× | 6.6× | 11.8× | 2.0% | 3.4× | n/a |
| DATATRAK International, Inc. · OTC:DTRK | US$7.65M | US$6.67M | 2.9× | 0.9× | 3.1× | 1.2× | 37.3% | 0.0× | 1.04 |
| Vitura Health Limited · ASX:VIT | US$7.46M | US$14.77M | n/a | 0.2× | 18.6× | 0.3× | −3.4% | 0.4× | n/a |
| CompuMed, Inc. · OTC:CMPD | US$7.13M | US$5.84M | n/a | 0.7× | 10.5× | 2.4× | −3.4% | 0.2× | 0.56 |
| Comprehensive Healthcare Systems Inc · TSXV:CHS | US$7.00M | US$6.81M | n/a | 1.6× | n/a | n/a | −65.3% | n/a | -0.01 |
| American Shared Hospital Services · AMEX:AMS | US$6.67M | US$16.93M | n/a | 0.6× | 13.2× | 0.3× | −7.7% | 0.8× | 0.22 |
| P3 Health Partners Inc. · NASDAQ:PIII | US$6.61M | US$84.57M | n/a | 0.1× | 31.0× | 0.1× | −3.3% | 1.1× | 0.50 |
| LataMed AI Corp · OTC:LMED | US$5.78M | US$5.78M | n/a | n/a | n/a | 0.8× | n/a | 0.0× | -0.15 |
| Median of the others | US$7.29M | US$6.74M | 8.7× | 0.7× | 10.5× | 0.8× | −3.4% | 0.3× | 0.36 |
Team and board
Officers
| Officer | Role |
|---|---|
| Kasinee Kuldiloke | Chief Executive Officer, Director |
| Chanachai Joonjiraporn | Chairman of the Executive Committee, Director |
Board
| Director | Role |
|---|---|
| Associate Professor Dr. Pornthep Anussornnitisarn | Chairman of the Board of Director |
| Associate Professor Areepan Sophonsritsuk | Independent Director |
| Bandit Anantamongkol | Director |
| Chanachai Joonjiraporn | Chairman of the Executive Committee, Director |
| Kasinee Kuldiloke | Chief Executive Officer, Director |
| Prof.Dr.Pitikhate Sooraksa | Independent Director, Chairman of the Nomination and Remuneration Committee |
| Puttipong Poomsuwan | Director |
| Wiwat Angsupipat | Independent Director, Chairman of the Audit Committee |
Financials
Annual, in THB
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 61.9M | 105.7M | 121.5M | 63.3M | 11.2M |
| Cost of revenue | 42.9M | 44.1M | 42.0M | 32.3M | 13.6M |
| Gross profit | 19.0M | 61.6M | 79.5M | 31.0M | -2.40M |
| Selling, general and administrative | 44.3M | 35.4M | 24.5M | 17.7M | 4.47M |
| Operating income | -25.3M | 26.2M | 55.0M | 13.4M | -6.87M |
| Depreciation and amortization | 13.8M | 12.5M | 10.4M | ||
| EBITDA | -11.5M | 38.7M | 65.4M | ||
| Interest expense | 4.39M | 4.67M | 4.48M | 2.31M | 150.0K |
| Income before tax | -21.7M | 24.2M | 51.1M | 12.6M | -6.38M |
| Net income | -17.4M | 22.2M | 41.0M | 10.1M | -5.14M |
| Earnings per share, basic | -0.04 | 0.05 | 0.09 | 0.02 | -0.01 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 467.3M | 508.5M | 113.2M | 23.0M | 360.0K |
| Short-term investments | 0 | 0 | 26.0M | 0 | 0 |
| Receivables | 0 | 0 | 200 | 260.0K | 70.0K |
| Inventory | 2.52M | 2.53M | 1.86M | 1.47M | 600.0K |
| Current assets | 472.6M | 517.7M | 141.3M | 24.7M | 1.03M |
| Total assets | 598.9M | 635.7M | 259.7M | 151.7M | 141.3M |
| Accounts payable | 1.68M | 3.03M | 3.28M | 8.98M | 4.39M |
| Current liabilities | 11.9M | 16.8M | 17.8M | 24.7M | 20.8M |
| Total liabilities | 70.5M | 78.1M | 82.4M | 95.3M | 95.0M |
| Shareholders' equity | 528.3M | 557.6M | 177.3M | 56.4M | 46.3M |
| Shares outstanding | 440.0M | 440.0M | 440.0M | 440.0M | 440.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | -13.9M | 28.1M | 61.4M | ||
| Capital spending | -46.0K | -2.45M | -281.3K | 0 | 0 |
| Free cash flow | -13.9M | 25.7M | 61.2M | ||
| Cash from financing | -19.4M | 349.2M | 60.2M | ||
| Dividends paid | -10.6M | -31.0M | 0 | ||
| Change in cash | -41.2M | 395.3M | 90.2M |
Cap table
Built by 6ix from Inspire IVF Public Company Limited’s releases
- Common shares
- 440,000,812
- Fully diluted
- 440,000,812
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 440,000,812 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 440,000,812 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Associate Professor Areepan Sophonsritsuk | Independent Director · Since at least Nov 4, 2026 |
| Associate Professor Dr. Pornthep Anussornnitisarn | Chairman of the Board of Director · Since at least Nov 4, 2026 |
| Bandit Anantamongkol | Director · Since at least Nov 4, 2026 |
| Chanachai Joonjiraporn | Chairman of the Executive Committee, Director · Since at least Nov 4, 2026 |
| Kasinee Kuldiloke | Chief Executive Officer, Director · Since at least Nov 4, 2026 |
| Prof.Dr.Pitikhate Sooraksa | Independent Director, Chairman of the Nomination and Remuneration Committee · Since at least Nov 4, 2026 |
| Puttipong Poomsuwan | Director · Since at least Nov 4, 2026 |
| Wiwat Angsupipat | Independent Director, Chairman of the Audit Committee · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Inspire IVF Public Company Limited.